Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neuphoria Therapeutics (NEUP) EBIT Margin (2024 - 2025)

Historic EBIT Margin for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q2 2025 value amounting to 43981.65%.

  • Neuphoria Therapeutics' EBIT Margin changed N/A to 43981.65% in Q2 2025 from the same period last year, while for Dec 2025 it was 23.83%, marking a year-over-year change of. This contributed to the annual value of 7.21% for FY2025, which is N/A changed from last year.
  • Neuphoria Therapeutics' EBIT Margin amounted to 43981.65% in Q2 2025.
  • Neuphoria Therapeutics' EBIT Margin's 5-year high stood at 43981.65% during Q2 2025, with a 5-year trough of 558.84% in Q4 2024.